Prolil endopeptidasa eta piroglutamil peptidasa I ... - Euskara

Bibliografia
Gil, J., 1997. Ontogenia de la actividad enzimática cerebral degradadora de TRH y
encefalinas. Análisis subcelular. In: Doktore tesia; Medikuntza eta Odontologia
Fakultatea). UPV/EHU, Leioa.
Gilbert, S. F., 1997. "Developmental Biology", Sunderland, Massachusetts.
Giorgi, O., De Montis, G., Porceddu, M. L., Mele, S., Calderini, G., Toffano, G. and
Biggio, G., 1987. Developmental and age-related changes in D1-dopamine
receptors and dopamine content in the rat striatum. Brain Res. 432, 283-290.
Gluckman, P. D. and Butler, J. H., 1983. Parturition-related changes in insulin-like
growth factors-I and -II in the perinatal lamb. J Endocrinol. 99, 223-232.
Goldstein, D. J. and Harris, H., 1981. Mammalian brain alkaline phosphatase:
expression of liver/bone/kidney locus. Comparison of fetal and adult activities.
J Neurochem. 36, 53-57.
Goldstein, D. J., Ropchak, T. G., Kelly, G. B. and Keiser, H. R., 1983. TRH reverses
the effect of captopril in the renal hypertensive rat. Eur J Pharmacol. 93, 293-
294.
Gomez, R. A., Pupilli, C. and Everett, A. D., 1991. Molecular and cellular aspects of
renin during kidney ontogeny. Pediatr Nephrol. 5, 80-87.
Gomori, G., 1954. Chromogenic substrates for aminopeptidase. Proc Soc Exp Biol
Med. 87, 559-561.
Goossens, F., De Meester, I., Vanhoof, G., Hendriks, D., Vriend, G. and Scharpe, S.,
1995. The purification, characterization and analysis of primary and secondarystructure
of prolyl oligopeptidase from human lymphocytes. Evidence that the
enzyme belongs to the alpha/beta hydrolase fold family. Eur J Biochem. 233,
432-441.
Goossens, F. J., Wauters, J. G., Vanhoof, G. C., Bossuyt, P. J., Schatteman, K. A.,
Loens, K. and Scharpe, S. L., 1996. Subregional mapping of the human
lymphocyte prolyl oligopeptidase gene (PREP) to human chromosome 6q22.
Cytogenet Cell Genet. 74, 99-101.
Gorio, A., Lesma, E., Madaschi, L. and Di Giulio, A. M., 2002. Co-administration of
IGF-I and glycosaminoglycans greatly delays motor neurone disease and
affects IGF-I expression in the wobbler mouse: a long-term study. J
Neurochem. 81, 194-202.
Greenberg, L. J., 1962. Fluorometric measurement of alkaline phosphatase and
aminopeptidase activities in the order of 10-14 mole. Biochem Biophys Res
Commun. 9, 430-435.
Greene, L. J., Spadaro, A. C., Martins, A. R., Perussi De Jesus, W. D. and Camargo, A.
C., 1982. Brain endo-oligopeptidase B: a post-proline cleaving enzyme that
inactivates angiotensin I and II. Hypertension. 4, 178-184.
Griffin, C. A., Giacchetti, G., Schambelan, M. and Sechi, L. A., 1997. Ontogenic
expression of renal and hepatic angiotensin II receptor genes in the rat.
Nephron. 76, 103-110.
Griffiths, E. C., 1985. Thyrotrophin releasing hormone: endocrine and central effects.
Psychoneuroendocrinology. 10, 225-235.
Griffiths, E. C., 1987. TRH and amyotrophic lateral sclerosis. Neurology. 37, 175-176.
Griffiths, E. C. and Bennett, G. W., 1983. Thyrotropin-releasing Hormone. Raven
Press, New york.
Griffiths, E. C. and McDermott, J. R., 1983. Enzymic inactivation of hypothalamic
regulatory hormones. Mol Cell Endocrinol. 33, 1-25.
228
Bibliografia